Cytek Biosciences, Inc. is a cell analysis solutions company. The Company is advancing the cell analysis tools by delivering high-resolution, high-content, and high-sensitivity cell analysis utilizing its patented Full Spectrum Profiling (FSP) technology. Its platform includes its core FSP instruments, the Cytek Aurora and Northern Lights systems and the Cytek Aurora CS cell sorter; the Cytek Orion reagent cocktail preparation system; the Enhanced Small Particle (ESP) detection technology; the flow cytometer and imaging products under the Amnis and Guava brands, and reagents, software and service to provide a comprehensive and integrated suite of solutions for its customers. Its Cytek Aurora and Northern Lights systems are used in the study of infectious diseases, immunology, immunotherapy, immuno-oncology, oncology, and drug discovery. The Cytek Orion reagent cocktail preparation system enables researchers to fully automate the preparation of antibody cocktails for flow cytometry.
企業コードCTKB
会社名Cytek Biosciences Inc
上場日Jul 23, 2021
最高経営責任者「CEO」Jiang (Wenbin)
従業員数648
証券種類Ordinary Share
決算期末Jul 23
本社所在地47215 Lakeview Boulevard
都市FREMONT
証券取引所NASDAQ OMX - NASDAQ BASIC
国United States of America
郵便番号94538
電話番号18779229835
ウェブサイトhttps://cytekbio.com
企業コードCTKB
上場日Jul 23, 2021
最高経営責任者「CEO」Jiang (Wenbin)
過去5年間の配当金総支払額は
0.00
米ドルである。

データなし